91 related articles for article (PubMed ID: 24709423)
1. Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.
Zhang S; Chung WC; Wu G; Egan SE; Xu K
Neoplasia; 2014 Feb; 16(2):158-67. PubMed ID: 24709423
[TBL] [Abstract][Full Text] [Related]
2. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.
Zheng X; Linke S; Dias JM; Zheng X; Gradin K; Wallis TP; Hamilton BR; Gustafsson M; Ruas JL; Wilkins S; Bilton RL; Brismar K; Whitelaw ML; Pereira T; Gorman JJ; Ericson J; Peet DJ; Lendahl U; Poellinger L
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3368-73. PubMed ID: 18299578
[TBL] [Abstract][Full Text] [Related]
3. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
Li D; Zhan Y; Wang N; Tang F; Lee CJ; Bayshtok G; Moore AR; Wong EWP; Pachai MR; Xie Y; Sher J; Zhao JL; Khudoynazarova M; Gopalan A; Chan J; Khurana E; Shepherd P; Navone NM; Chi P; Chen Y
Sci Adv; 2023 Apr; 9(14):eadc9446. PubMed ID: 37018402
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Notch Signaling and Cell-Differentiation Inhibitory Transcription Factors in Stable Chronic Obstructive Pulmonary Disease Patients.
Di Stefano A; Gnemmi I; Rosani U; Maniscalco M; D'Anna SE; Brun P; Carriero V; Bertolini F; Balbi B; Ricciardolo FLM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542260
[TBL] [Abstract][Full Text] [Related]
5. Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.
Packer JR; Hirst AM; Droop AP; Adamson R; Simms MS; Mann VM; Frame FM; O'Connell D; Maitland NJ
FEBS Lett; 2020 Jan; 594(2):209-226. PubMed ID: 31468514
[TBL] [Abstract][Full Text] [Related]
6. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
[TBL] [Abstract][Full Text] [Related]
8. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
[TBL] [Abstract][Full Text] [Related]
9. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.
Belle VA; McDermott N; Meunier A; Marignol L
Nat Rev Urol; 2014 Sep; 11(9):499-507. PubMed ID: 25134838
[TBL] [Abstract][Full Text] [Related]
10. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1.
Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y
Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992
[TBL] [Abstract][Full Text] [Related]
11. Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.
Chung WC; Zhang S; Challagundla L; Zhou Y; Xu K
Neoplasia; 2017 Nov; 19(11):885-895. PubMed ID: 28938159
[TBL] [Abstract][Full Text] [Related]
12. Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
Li J; Hilimire TA; Liu Y; Wang L; Liang J; Gyorffy B; Sikirzhytski V; Ji H; Zhang L; Cheng C; Ding X; Kerr KR; Dowling CE; Chumanevich AA; Mack ZT; Schools GP; Lim CU; Ellis L; Zi X; Porter DC; Broude EV; McInnes C; Wilding G; Lilly MB; Roninson IB; Chen M
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38546787
[TBL] [Abstract][Full Text] [Related]
13. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
[TBL] [Abstract][Full Text] [Related]
14. Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming.
Wang J; Chen S; Pan C; Li G; Tang Z
Front Bioeng Biotechnol; 2022; 10():799152. PubMed ID: 35875485
[TBL] [Abstract][Full Text] [Related]
15. Notch Signaling Pathway in Cancer-Review with Bioinformatic Analysis.
Anusewicz D; Orzechowska M; Bednarek AK
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673145
[TBL] [Abstract][Full Text] [Related]
16. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis.
Orzechowska M; Anusewicz D; Bednarek AK
Front Cell Dev Biol; 2020; 8():592616. PubMed ID: 33384996
[TBL] [Abstract][Full Text] [Related]
17. Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings.
Goruganthu MUL; Shanker A; Dikov MM; Carbone DP
Front Immunol; 2020; 11():1958. PubMed ID: 32922403
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Principles of Pattern Formation Driven by Notch Signaling by Integrating Experiments and Theoretical Models.
Bocci F; Onuchic JN; Jolly MK
Front Physiol; 2020; 11():929. PubMed ID: 32848867
[TBL] [Abstract][Full Text] [Related]
19. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
20. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
